Natural Products for the Prevention, Treatment and Progression of Breast Cancer
- PMID: 37296944
- PMCID: PMC10252020
- DOI: 10.3390/cancers15112981
Natural Products for the Prevention, Treatment and Progression of Breast Cancer
Abstract
In this review, we summarize the most used natural products as useful adjuvants in BC by clarifying how these products may play a critical role in the prevention, treatment and progression of this disease. BC is the leading cancer, in terms of incidence, that affects women. The epidemiology and pathophysiology of BC were widely reported. Inflammation and cancer are known to influence each other in several tumors. In the case of BC, the inflammatory component precedes the development of the neoplasm through a slowly increasing and prolonged inflammation that also favors its growth. BC therapy involves a multidisciplinary approach comprising surgery, radiotherapy and chemotherapy. There are numerous observations that showed that the effects of some natural substances, which, in integration with the classic protocols, can be used not only for prevention or integration in order to prevent recurrences and induce a state of chemoquiescence but also as chemo- and radiosensitizers during classic therapy.
Keywords: breast cancer; chemoscience; natural anticancer agents; prolonged inflammation.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
A Review of Twenty Years of Research on the Regulation of Signaling Pathways by Natural Products in Breast Cancer.Molecules. 2022 May 25;27(11):3412. doi: 10.3390/molecules27113412. Molecules. 2022. PMID: 35684353 Free PMC article. Review.
-
Multidisciplinary therapy of locally far-advanced or inflammatory breast cancer with fixed perioperative sequence of epirubicin, vinorelbine, and Fluorouracil chemotherapy, surgery, and radiotherapy: long-term results.Oncologist. 2006 Jun;11(6):563-73. doi: 10.1634/theoncologist.11-6-563. Oncologist. 2006. PMID: 16794236 Clinical Trial.
-
The role of dietary factors in prevention and progression of breast cancer.Anticancer Res. 2014 Dec;34(12):6861-75. Anticancer Res. 2014. PMID: 25503112 Review.
-
Cost-effectiveness analysis of ovarian function preservation with GnRH agonist during chemotherapy in premenopausal women with early breast cancer.Hum Reprod. 2023 Jun 1;38(6):1099-1110. doi: 10.1093/humrep/dead073. Hum Reprod. 2023. PMID: 37075316
-
Effects and mechanisms of dietary bioactive compounds on breast cancer prevention.Pharmacol Res. 2022 Apr;178:105974. doi: 10.1016/j.phrs.2021.105974. Epub 2021 Nov 21. Pharmacol Res. 2022. PMID: 34818569 Review.
Cited by
-
Dioscin inhibits non-small cell lung cancer cells and activates apoptosis by downregulation of Survivin.J Cancer. 2024 Jan 20;15(5):1366-1377. doi: 10.7150/jca.89831. eCollection 2024. J Cancer. 2024. PMID: 38356707 Free PMC article.
-
Phytochemicals Involved in Mitigating Silent Toxicity Induced by Heavy Metals.Foods. 2024 Mar 22;13(7):978. doi: 10.3390/foods13070978. Foods. 2024. PMID: 38611284 Free PMC article. Review.
-
Computational identification of potential natural terpenoid inhibitors of MDM2 for breast cancer therapy: molecular docking, molecular dynamics simulation, and ADMET analysis.Front Chem. 2025 Apr 16;13:1527008. doi: 10.3389/fchem.2025.1527008. eCollection 2025. Front Chem. 2025. PMID: 40308267 Free PMC article.
-
Neuroprotective Effects of Curcumin in Neurodegenerative Diseases.Foods. 2024 Jun 5;13(11):1774. doi: 10.3390/foods13111774. Foods. 2024. PMID: 38891002 Free PMC article. Review.
-
Phytocompounds and Nanoformulations for Anticancer Therapy: A Review.Molecules. 2024 Aug 9;29(16):3784. doi: 10.3390/molecules29163784. Molecules. 2024. PMID: 39202863 Free PMC article. Review.
References
-
- Buchta Rosean C., Bostic R.R., Ferey J.C.M., Feng T.Y., Azar F.N., Tung K.S., Dozmorov M.G., Smirnova E., Bos P.D., Rutkowski M.R. Preexisting commensal dysbiosis is a host-intrinsic regulator of tissue inflammation and tumor cell dissemination in hormone receptor-positive breast cancer. Cancer Res. 2019;79:3662–3675. doi: 10.1158/0008-5472.CAN-18-3464. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources